The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)
Publication
, Conference
Gupta, S; Yang, Q; Halabi, S; Tubbs, A; Gore, Y; George, DJ; Nanus, DM; Antonarakis, ES; Danila, D; Szmulewitz, R; Wenstrup, RJ; Armstrong, AJ
Published in: ANNALS OF ONCOLOGY
2022
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2022
Volume
33
Issue
7
Start / End Page
S1165 / S1166
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gupta, S., Yang, Q., Halabi, S., Tubbs, A., Gore, Y., George, D. J., … Armstrong, A. J. (2022). The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC). In ANNALS OF ONCOLOGY (Vol. 33, pp. S1165–S1166).
Gupta, S., Q. Yang, S. Halabi, A. Tubbs, Y. Gore, D. J. George, D. M. Nanus, et al. “The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC).” In ANNALS OF ONCOLOGY, 33:S1165–66, 2022.
Gupta S, Yang Q, Halabi S, Tubbs A, Gore Y, George DJ, et al. The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC). In: ANNALS OF ONCOLOGY. 2022. p. S1165–6.
Gupta, S., et al. “The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC).” ANNALS OF ONCOLOGY, vol. 33, no. 7, 2022, pp. S1165–66.
Gupta S, Yang Q, Halabi S, Tubbs A, Gore Y, George DJ, Nanus DM, Antonarakis ES, Danila D, Szmulewitz R, Wenstrup RJ, Armstrong AJ. The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC). ANNALS OF ONCOLOGY. 2022. p. S1165–S1166.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2022
Volume
33
Issue
7
Start / End Page
S1165 / S1166
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis